Annual Report 2019

2 The United Laboratories International Holdings Limited Annual Report 2019 January • The United Laboratories was honored “2018 Golden Hong Kong Stocks – Most Valuable Pharmaceutical Company and Medical Stock”. February • The United Laboratories was honored “Medical Technology Innovation Advanced Company of Zhuhai for 2018”. March • The United Laboratories was further listed as one of the “China Top Ten Member Exporters of APIs”. • The United Animal Healthcare (Inner Mongolia) Co., Ltd. passed the “High-Tech Enterprise” certification. • “Double-Excellence Action – Grassroots Diabetes Prevention and Treatment Management Training Course” was kicked off in Zhengzhou, Henan Province. April • “2019 Forum on Hospital Pharmacy Changes and Development in the Context of Healthcare and Medical Institution Reform”, sponsored by The Science and Technology Development Center of Chinese Pharmaceutical Association and co-sponsored by The United Laboratories, was held successfully in Zhuhai, Guangdong. • The United Laboratories Clinical Department (Guangzhou branch) was established. May • The United Animal Healthcare (Inner Mongolia) Co., Ltd. was named “China’s Leading Domestic Brand” at Brand Summit China 2019. June • The United Laboratories was awarded “Quality Suppliers and Partners in the World Market” and “Prize of Special Contribution for CCCMHPIE’s 30th Anniversary” by China Chamber of Commerce for Import & Export of Medicines & Health Products. July • Mr. Tsoi Hoi Shan, Chairman of the Board of The United Laboratories, was honored as “Guangdong New Economy – Outstanding Entrepreneur” for the year of 2019. • The United Laboratories was listed among “2018 China Pharmaceutical Industry Top 100 Companies” and ranked 25th. • Powder injection of “Amoxicillin and Clavulanate Potassium for Injection”, a veterinary product developed by The United Animal Healthcare (Inner Mongolia) Co., Ltd., was approved for marketing. CORPORATE CALENDAR OF 2019